Carob Market 2022 Outlook, Current and Future Industry Landscape Analysis 2027

Carob (Ceratonia siliqua) is a native plant to the eastern Mediterranean especially to the Middle East countries. Carob is also called as locust bean and is primarily cultivated for its edible pods in majorly Mediterranean region which includes Southern Europe, Northern Africa and the Canary Islands. Carob powder is also used as a substitute for cocoa powder in various bakery products. Carob based bars is consumed as an alternative to chocolate based bars worldwide. Carob do not contain caffeine and theobromine (which is intolerant to some animals) and therefore is widely used in chocolate flavored pet food for dogs and other animals. Carob pod meal is widely used as a rich source of energy for livestock, particularly for ruminants. Carob in food industry is used as a thickening agent, gelling agent, stabilizing agent or as a substitute for low-calorie food products. Carob is fat-free, rich in pectin and contains high amount of proteins. Carob is primarily used in the production of confectionery and bakery products and variety of beverages. Carob is also used for making flour, molasses and is a substitute for coffee.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3335

Global Carob: Market Segmentation

The global carob market is segmented on the basis of form, distribution channel, application and region. The carob market is segmented on the basis of form such as solid and liquid. The carob market is segmented on the basis of distribution channel which includes fitness stores, health stores, online and others. The carob market is segmented on the basis of application such as bakery products which includes cakes, cookies, pancakes, bread. Carob is also used in snack bars, cocoa based food products and beverages, cereals, dairy products and others. Carob pod meal is widely used for livestock. Carob syrup is used as a natural sweetener and is considered as a rich source of calcium. Hence, the global carob market is expected to significantly increase the revenue contribution over the forecast period.

Global Carob Market: Regional Outlook

Geographically, the global carob industry can be divided by major regions which include North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, Japan and Middle East and Africa. Globally, among all regions, Europe has developed as the dominant region in global carob market followed by Asia Pacific. Increasing demand for carob powder in various bakery products and confectionery, has strengthened the growth of global carob market and hence is projected to significantly expand the revenue contribution of the market over the forecast period.

Global Carob Market: Growth Drivers

The global carob market driving factors are increasing demand for bakery products coupled with the convenience of foods. Increasing opportunities in bakery and confectionery industry is also another factor in driving the carob market along with rise in production of carob. Carob is also used for treating diarrhea, cancer, helps in reducing cholesterol level, and are some of the factors driving the global carob market. Carob powder is widely used as an alternative for cocoa powder due to its health benefits which is a major driving factor for the global carob market. Hence, the global carob market is expected to observe robust growth over the forecast period.

Global Carob Market: Key Players

Some of the key players identified across the value chain of the global carob market include Australian Carobs Pty Ltd., CAROB S.A., EURODUNA AMERICAS INC., CyberColloids Ltd., The Hain Celestial Group, Inc., Savvy Foods Ltd., Carobs Australia Inc., Creta Carob, Lewis Confectionery Pty Ltd and MADANARGAN. The companies are expected to expand their business by enhancing their product portfolio in global carob market. The companies are projected to frame certain strategies in future in order to gain the competitive advantage in global carob market till 2027.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-3335

The report covers exhaustive analysis on:

  • Carob Market Segments
  • Carob Market Dynamics
  • Historical Actual Market Size, 2015 – 2016 for Global Carob Market
  • Carob Market Size & Forecast 2017 to 2027
  • Supply & Demand Value Chain
  • Carob Market Current Trends/Issues/Challenges
  • Competition & Companies involved in Global Carob Market
  • Technology
  • Value Chain
  • Global Carob Market Drivers and Restraints

Regional analysis for Global Carob Market include

  • North America
    • US & Canada
  • Latin America
    • Brazil, Mexico, Others
  • Western Europe
    • EU5
    • Nordics
    • Benelux
  • Eastern Europe
    • Russia
    • Poland
    • Rest of Eastern Europe
  • Asia Pacific
    • Australia and New Zealand (ANZ)
    • Greater China
    • India
    • ASEAN
    • Rest of Asia Pacific
  • Japan
  • Middle East and Africa
    • GCC Countries
    • Other Middle East
    • North Africa
    • South Africa
    • Other Africa

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/3335

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Contact Us:                                                                            

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Cardiac Ultrasound Systems Market 2021 Outlook, Current and Future Industry Landscape Analysis 2031

The cardiac ultrasound systems market exhibited year-on-year growth of 5.9% in 2021, backed by introduction of mobile connectivity in handheld wireless cardiac ultrasound systems and growing preference for real-time imaging solutions among patients. Future Market Insights (FMI) states that cardiac ultrasound systems market revenue grew by 6% between 2016 and 2020. It is predicted that sales will increase at a CAGR of 5.0% between 2021 and 2031.

Growing preference for connected ultrasound systems for real-time diagnosis among patients marks a recent milestone, shaping the performance of cardiac ultrasound systems landscape.

The World Health Organization (WHO) reports that more than 17 million people die from cardiovascular disorders globally each year. Rise in referrals to cardiologists due to complications and rapid technological advancements to make the existing cardiac ultrasound devices more compact and user-friendly will positively influence the market growth throughout the forecast period.

The global cardiac ultrasound systems landscape is slated for positive growth prospects in the near future due to increasing efforts to develop stronger distribution channel and manufacturers switching to emerging countries to attain high return of investments.

Surge in number of specializations in imaging and radiological technology along with dramatically growing number of independent imaging centers will provide impetus to revenue growth in upcoming years.

Portable cardiac ultrasound systems are expected to exhibit remarkable market penetration in recent years, due to growing popularity of bedside ultrasonography among people.

Lack of favorable reimbursement and insurance policies along with high cost of equipment are impeding the sales of cardiac ultrasound systems, especially in developing economies.

Lack of adequate grants from government and requirement of high capital investments for installation of modern cardiac ultrasound systems will further hinder the market growth.

Key Takeaways from FMI’s Cardiac ultrasound systems Market Study

  • North America cardiac ultrasound systems market will exhibit steady growth at 4.70% CAGR through 2031, driven by increasing demand for portable and attractive cardiac devices among cardiologists in U.S. and Canada.
  • European cardiac ultrasound systems market led by Germany, France, and Italy is forecast to grow at 5.30% CAGR during the forecast period. Rise in growth can be attributed to increasing government spending on healthcare and presence of top manufacturers in the region.
  • Increasing cases of cardiovascular and lifestyle diseases in India will drive the demand for cardiac ultrasound systems in the country.
  • In 2021, Japan and South Korea are estimated to account for 20% and less than 4% share respectively of the Asia Pacific cardiac ultrasound system market. Rising geriatric population and increasing popularity of online sales are key growth drivers in these countries.
  • By product type, hand-held ultrasound systems sales are projected to surpass the market valuation of US$ 2,300 Mn at a CAGR of 6.5% in 2021. Integration of 4D imaging technology and internet of things (IoT) will drive the market growth of this segment.

Request Complete TOC Of this Report @ https://www.futuremarketinsights.com/toc/rep-gb-7692

Who is Winning?

Future Market Insights presents analysis on the key trends affecting the cardiac ultrasound systems market and discusses the strategies adopted by market players to strengthen their position. It estimated that the cardiac ultrasound systems market is dominated by GE Company, Fujifilm, Holdings Corporation, Siemens AG, Koninklijke Philips N.V., Toshiba Medical System Corp., Hitachi Medical Corp., and Esaote SpA as they hold majority of market share in 2021.

Leading market players are focusing on strategic merger, acquisitions, and partnerships to expand their product portfolio. Smaller players are concentrating on strengthening their value chain to gain significant market share, says FMI.

In order to cater growing the patient pool with cardiovascular diseases and high demand for non invasive diagnostics, manufacturers are focusing on new product development.

In 2020, Siemens Healthineers India launched new ACUSON redwood ultrasound system at Gandhinagar. This advanced system precisely detects lesions and characteristics. It is installed with artificial intelligence (AI) powered tools to reduce the exam burden and improve efficiency.

In 2018, Philips introduced new cardiac ultrasound solutions “EPIQ CVx” equipped with anatomical intelligence which offers customized applications for diagnostic, pediatric and interventional echocardiography. EPIQ CVx has faster data processing, high quality imaging, and automated quantification and tailored exam tools developed to assist cardiologists in delivering better care.

Prominent players operating in the cardiac ultrasound systems market are:-

  • Hitachi, Ltd.
  • Analogic Corporation
  • Toshiba Corporation
  • Esaote SpA
  • Samsung Medison Co. Ltd
  • FUJIFILM Holdings Corporation
  • Mindray Medical International Ltd.
  • GE Healthcare

Narcolepsy Treatment Market 2018 Outlook, Current and Future Industry Landscape Analysis 2028

Revenue from narcolepsy treatment, globally is projected to stand at a valuation of US$ 3,818 Mn, registering an annual growth rate of 5.7 percent, from 2018-2028. Future Market Insights (FMI), in its newly published market intelligence outlook, highlights substantial demand for narcolepsy treatment in North America. Narcolepsy treatment landscape in Europe, will witness significant revenue growth given the rising affinity toward adoption of prescription treatments and adherence to the same on a long term basis.

Asia Pacific among other emerging economies including MEA and Latin America, on the other hand, are expected to showcase positive trends towards the adoption of narcolepsy treatment, due to:

  • Strong distribution pipeline of the narcolepsy drugs.
  • Emerging global and local biopharmaceutical companies.
  • Increasing incidences of Obstructive Sleep Apnea (OSA) in Latin America. Obesity is reported to be the most common risk factor.
  • Prevalence of moderately severe sleep apnea is estimated to be around 5% in women and 10% in men in South Africa. It is estimated that up to 90% of patients are undiagnosed.
  • Prevalence of sleep apnea is more severe in the developing countries due to the lack of skilled physicians

In term of key forward market strategies, the primary objective manufacturers in the narcolepsy treatment market is to expand their footprint in the various regional markets, in order to solidify their market position.

Key Findings from the Regional and Competitive Landscape Analysis of Narcolepsy Treatment Market

  • Leading narcolepsy treatment manufacturers are prioritizing regional-specific product development. The product portfolio expansion is mostly targeted in Asia Pacific.
  • Apart from new product development—mostly arising from the presence of low cost generic versions of patented drugs, strategic partnerships and acquisitions with pave way for further business expansions.
  • Manufacturers in the global narcolepsy treatment are also focused towards introducing new research and development units in different geographic regions.
  • Industry leaders are focusing on maintaining long-term partnerships with pharmacies- in hospital and retail, drug stores, and e-commerce. Sales through e-commerce distribution channel is expected to contribute a significant revenue share in the global narcolepsy treatment market.
  • FMI, has also noted an increasing focus on reformulation of well-known products and combinations, by manufacturers in North America in order to achieve higher sales and wide penetration.

Request Complete TOC Of this Report @ https://www.futuremarketinsights.com/toc/rep-gb-7641

Increasing Prescription of Sleep Aids

According to CDC, around 50 to 70 Million Americans suffer from some sleep disorders and sleep deprivation conditions. Approximately 4% of the U.S. adults aged 20 and above use prescribed sleep aids as well as wearable sleep trackers. The percentage of the population using prescription sleep aids is increasing with education and age. About 9 Million U.S. adults take prescription sleep aids, wherein women (5.0%) use more prescription sleep aids than men (3.1%). This increase in the prescription of sleep aids is expected to boost the market of narcolepsy treatment globally.

narcolepsy treatment market

There is a conscious shift from OTC medication to devices treating narcolepsy, driving significant revenue growth for the devices segment compared to drugs.  Growing incidences of inappropriate medication and addiction, translating into severe side effects including headache, prolonged drowsiness, daytime memory and performance problems, allergic reactions, and death in some cases, is the key driving factor. These side effects are associated with OTC as well as prescription-based sleep aids. Growing demand to treat narcolepsy with BiPAP is expected to push this segment of devices—predicted to expand at the highest CAGR. Moreover, devices in portable and available-for-rent formats, will translate into higher adoption rates, throughout the forecast period. Portable Continuous positive airway pressure (CPAP) devices are lighter and smaller and can also be used as a home based unit, further reducing the dependency on OTC pills and prescription drugs.

While explaining the growth trajectory of narcolepsy treatment market, a senior analyst from the healthcare domain underscores growing healthcare expenditure and rising incidence cases of fracture fixation and orthopedic disorders as key factors contributing to the demand of narcolepsy treatment though 2028. “Regulatory impositions by various global authorities including the FDA and European Commission along with currency fluctuations, regulations and changing taxation policies are some high-impact factors pushing the global demand for narcolepsy treatment”, the analyst further explains.

Critical Market Restrainers

Although the narcolepsy market is expanding at a robust CAGR, long waiting time for sleep services, lack of awareness and delayed diagnosis, severe side effects of sleep aids medication, lack of proper documentation for the usage and licensing of sleeping pills, and improper equipment regulations are some critical factors projected to restrain the growth of narcolepsy treatment market.

Segmentation

The report offers a comprehensive taxonomy of the narcolepsy treatment market on the basis of product type, distribution channel and region. On the basis of product type, the global narcolepsy treatment market has been segmented into narcolepsy treatment drugs and devices.

On the basis of distribution channel, the global narcolepsy treatment market has been segmented into retail pharmacies, hospital pharmacies, e-commerce, drug stores and others. From a geographical perspective, the narcolepsy treatment market has been segmented into North America, Latin America, Europe, Asia Pacific and Middle East & Africa (MEA).

Vein Finder Market 2022 Outlook, Current and Future Industry Landscape Analysis 2028

Advancements in healthcare technology have fuelled a spate of innovations in medical devices, with top-of-the-line product launches presenting enhanced device functionalities. Innovations in vein finder technology are taking the medical devices sector by storm, with advanced vein finders backed by latest technologies acting as a boon for physicians, nurses, and phlebotomists. The last two years have witnessed notable innovations in vein finder technology, the prominent ones being:

  • The world’s first slide style palm vein authentication technology was introduced in the vein finder market by Fujitsu Laboratories Ltd. in 2017. This compact technology is capable of being integrated into tablets and benchtop mobile devices.
  • In 2018, Vino Optics launched the Oxy-Iso Paramedic vein glasses, a pair of sunglasses to help physicians and phlebotomists easily locate veins through enhanced image display by filtering ultraviolet rays. This technology is supposedly beneficial for healthcare professionals suffering from colour blindness, as these vein finders help physicians locate veins by enhancing their ability to view reds and greens.

2013-2021 Vein Finder Market Demand Outlook Compared to 2022-2028 Forecast

Sales of vein finder grew at a CAGR of 9.0% between 2013 and 2021.

The market for vein finder is growing significantly owing to their rising accuracy and reliability in locating veins and is one of the key factors increasing the demand and growth of vein finder market. The development of the market is mainly attributed to technological developments in the healthcare technology that have helped in innovation of new medical devices.

Rising trend of mobile health is likely to boost the adoption of vein finder among healthcare institutions. It is projected that more than 350,000 mHealth apps were available on app stores in 2020. Recently, advanced mobile apps which use sophisticated software to scan the skin of the patients have arrived into the market.

Moreover, in the past few years, the amount of cosmetic surgeries amongst the geriatric population has increased. Surgeries such as facelift, tightening of the skin, body & facial contouring, brow lift, eyelid lift, etc. are very popular. This surge in the number of surgeries increases the demand for vein finder devices.

Considering this, FMI expects the global vein finder market to grow at a CAGR of 10.9% through 2028.

vein finder market

Request Complete TOC Of this Report @ https://www.futuremarketinsights.com/toc/rep-gb-7640

Vein Finder Market Structure Overview: Regional Focus to Bolster Global Market Growth

An overview of the market structure of the global vein finder market reveals a strong regional presence of top market companies as well as local players. Leading companies operating in the global vein finder market are leveraging acquisitions as a primary strategy to facilitate regional market expansion. Future Market Insights analysis also observes a strong focus by vein finder companies on R&D for new product development and expansion of the existing product line in key regional growth markets.

“Implementation of inorganic growth strategies is seen as the way forward to penetrate key growth markets across certain developing regions. Companies in the vein finder market with diversified product offerings are collaborating with local regional players to introduce low-cost vein finder products in order to cement their presence across top regional markets.”

In 2017, the leading three companies in the global vein finder market held a revenue share of about 56% while the remaining players contributed about 44% market share. New product development is a key strategy adopted by players in the global vein finder market to increase their brand value. Rising difficulties associated with peripheral venous access and venepuncture is one of the primary factors boosting growth of the vein finder market and key players are capitalizing on the growth drivers to increase their market share.

Future Market Insights predicts lucrative revenue growth in the various regional markets of Europe and Asia Pacific Excluding Japan. Europe will likely remain the top market for sales of vein finder devices owing to increasing adoption of vein finder across hospitals and clinics to locate veins for drawing blood samples, IV insertions, and other vascular procedures.

Portable Vein Finder to Garner Maximum End User Demand; Infrared Technology to Register Fastest Growth in Revenue, Reveals Future Market Insights

Portable vein finders are likely to be the most preferred product type in the global vein finder market, registering impressive demand as well as sales growth in the coming decade. The convenience and ease of use offered by portable vein finders is the primary factor boosting adoption across hospitals, clinics, and other healthcare institutions. The global vein finder market is fuelled by advanced technology with infrared technology being the most adopted in vein finders. Among the various end users of vein finders, hospitals are likely to exhibit the highest demand in the next 10 years, also contributing to maximum revenues in the global vein finder market.

Vein Finder Market by CategoryBy Product:

  • Portable
  • Benchtop

By Technology:

  • Ultraviolet
  • Infrared
  • Ultrasound

By End User:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Centers and Path Labs
  • Veterinary Clinics
  • Home Care Settings
  • Blood Banks

By Region:

  • North America
  • Latin America
  • Europe
  • CIS & Russia
  • Asia Pacific excluding Japan (APEJ)
  • Japan
  • Middle East and Africa (MEA)

Oxycodone Market 2021 Outlook, Current and Future Industry Landscape Analysis 2031

ESOMAR-certified consulting firm Future Market Insight (FMI) has published a report on the global oxycodone market for the forecast period of 2021 – 2031. According to the report, the market is expected to expand at a CAGR of 4.8% during the forecast period.

Oxycodone belongs to a group of opioid analgesics that is generally used in pain management. It is used for both long and short term. Rising prevalence of orthopaedic diseases such as osteoporosis, fibromyalgia, rheumatoid arthritis and other types of chronic pain is boosting the demand for oxycodone in the global market.

According to the International Osteoporosis Foundation, osteoporosis is one of the most serious health concerns among women and around 30% of people in U.S and Europe are affected by it each year. Increasing medical ailment and post-operative pain is another factor influencing the demand for oxycodone market globally.

The market growth is expected to accelerate due to increasing research and development activities undertaken to innovate abuse-deterrent formulations. Advance drug formulation such as extended-release medication for pain relief is an example of improve formulation.

The market however could face certain restrains in growth as oxycodone has side effects such as bladder pain, abdominal cramps, vomiting, diarrhoea, and breathing problem. Moreover, overdose of oxycodone can lead to de-addiction. The market can also be impacted due to certain severe adverse psychological problems such as depression.

COVID-19 pandemic has affected healthcare industry as there has been a sharp reduction in demand due to lesser visits to healthcare facilities such as clinics and hospitals. The widespread of virus has affected workforce in hospitals and other staffing issues as well.

Request Complete TOC Of this Report @ https://www.futuremarketinsights.com/toc/rep-gb-7638

Key Takeaways from FMI’s Oxycodone Market Study

  • Increasing penetration of pain management drugs, coupled with favourable reimbursement policies will drive sales in the U.S.
  • Within the Middle East and Africa, the demand in GCC countries will rise backed by investment towards expansion of the healthcare sector
  • The U.K., Italy, and France are likely to account for sizeable share in the Europe market for oxycodone
  • Long-acting oxycodone sales will rise steadily owing to surging application in pain management
  • Hospital pharmacies will continue exhibiting high demand for oxycodone, driven by higher footfall of patients

Who is Winning?

The key payers operating in the global oxycodone market are focusing on adopting numerous strategies such as mergers and acquisitions, research and development activities, and joint ventures. The key players operating in the global market are Janssen Pharmaceuticals (A Johnson and Johnson Subsidary), Inc., Purdue Pharma L., Hikma Pharmaceuticals USA, Inc., Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Sanofi-Aventis S.A., and others.

  • FDA in 2017 approved RoxyBond, a novel formulation of immediate-release oxycodone. This is the first approved immediate release opioid analgesic formulation with labelling that describes its abuse-deterrent properties.
  • In September 2019, Daiichi Sankyo Company in Japan, launched its generic formulated oxycodone hydrochloride hydrate extended release tablets for cancer pain treatment.

Key Segments Covered in Oxycodone Market Study

By Oxycodone Type:

  • Long-acting oxycodone
  • Short-acting oxycodone

By Application:

  • Pain Management
  • De-addiction

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Endoscopy Visualization Systems Market 2022 Outlook, Current and Future Industry Landscape Analysis 2028

Around 3/4th share of the total revenue of endoscopy visualization systems landscape is accounted by Tier 1 players that are prominently focusing on cost effective product development

  • Leaders in endoscopy visualization systems landscape are also prioritizing innovative product launches, product portfolio extension, and strategic collaborations and mergers for an even stronger market footprint.
  • Tier 2 and Tier 3 companies, making up for the rest of market revenue, are particularly focusing on regional expansion – especially targeting developing Asian economies.

Prominently due to the paradigm shift to value based, sophisticated healthcare system and a mounting number of strategic mergers and acquisitions between leading medical device manufacturers, endoscopy visualization systems have been witnessing robust demand in recent years.

“With an ever growing demand for minimally invasive surgical procedures and growing availability of low-cost diagnostic procedures, we expect robust expansion of the global revenue through endoscopy visualization systems. While endoscopy visualization systems currently account for a billion dollar market globally, it is more likely that the endoscopy visualization systems landscape will observe over 7% year on year growth in 2019. Relatively undemanding FDA clearance guidelines is another strong factor pushing the prospects for endoscopy visualization systems in the near future,” says a senior research analyst at Future Market Insights.

Innovation of Endoscopy Visualization Systems Takes a Grand Leap beyond 3D Imaging

The 3D endoscope visualization system has been an impactful innovation in the endoscope visualization systems landscape. While 3D visualization technology offers a deeper view of the diagnostic area during endoscopic procedures, constant R&D efforts have directed the innovations to the latest – customized 3D visualization. The world’s first-ever endoscopy visualization system (by MedicalTek) has been recently launched that works on an easy-to-set and easy-to-alter imaging technique and offers an adjustable 3D perception to resultant endoscopic images.

Product Type Assessment: Adapting to the Trend of Minimally Invasive Surgery Demand, High-range Endoscopy Visualization Systems Remain the Top Seller

The FMI analyst explains that ever-growing demand for minimally invasive surgical procedures worldwide, it is quite clear that high-range endoscopy visualization systems will continue to bring in maximum revenue to the marketplace. With a current market value share of around 50%, high-range endoscopy visualization systems will be the highest selling type of EVS owing to favorable reimbursement policies and availability of advanced technology systems in this segment. Mid-range endoscopy visualization systems are also identified to capture a considerable market value share in 2019, demonstrating the year-on-year expansion of over 7%.

Request Complete TOC Of this Report @ https://www.futuremarketinsights.com/toc/rep-gb-7596

Diagnostic Area-wise Analysis: Maximum Opportunities Exist for GI Tract Endoscopy Visualization Systems

Recent statistical data published by American Society of Gastrointestinal Endoscopy (ASGE) indicates that among roughly 75 million endoscopic procedures annually performed at a global level, more than 65% are performed on the gastrointestinal tract, followed by the female reproductive tract. A considerable number of endoscopies are also performed through a small-sized incision with an objective to achieve least invasion. According to FMI’s projection for 2019, the year on year revenue growth will be around 7% in case of gastrointestinal tract endoscopy visualization systems, whereas that in case of small-sized incision procedures will be more than 7%.

What is COVID-19 Impact on endoscopy visualization systems market?

A country-level lockdown impacted the endoscopy visualization systems market negatively. The pandemic resulted in a global decline in medical device demand. The market for endoscopy visualization systems was also hampered due to the cancellation or postponement of elective and non-urgent endoscopic treatments.

Furthermore, strict endoscopy facilities regulations led to reduced surgical volume even more. Because of the government’s stringent measures, manufacturers, sellers, and distributors in the market continued to be impacted by the pandemic. Aside from that, a number of government-run cancer screening programs and projects have been suspended or cancelled. However, the use of single-use disposable endoscopes saw a tremendous rise during the same time period which enabled improved infection management.

endoscopy visualization systems market

Regional Outlook: Asia Pacific Becomes an Attractive Growth Platform for Manufacturers of Endoscopy Visualization Systems

While developing economies are constructing a lucrative base for the growth of endoscopy visualization systems landscape through changing demographics and an expanding patient pool, Future Market Insights offers exclusive insights on the same. An elevating number of endoscopy visualization systems predominantly for disorders of GI tract, female reproductive system, urinary tract, and respiratory system is encouraging the sales of endoscopy visualization systems in emerging Asian economies.

The FMI analyst says while unfolding the key attributes driving expansion of market within emerging regional territories, “While APEJ is at present the second largest market for endoscopy visualization systems after North America, Japan is also witnessing significant growth. This growth can be attributed to both, a healthy rate adoption of endoscopy visualization systems at hospitals, and impressively growing sales at specialty clinics”.

Endoscopy visualization systems market by CategoryBy Product Type

  • High Range EVS
  • Mid-Range EVS
  • Low Range EVS

By Area

  • Gastrointestinal Tract
  • Respiratory Tract
  • Ear
  • Urinary Tract
  • Female Reproductive Tract
  • Through a small incision

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Diagnostic Imaging Centers

By Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia-Pacific Ex. Japan
  • Japan
  • Middle-East & Africa

Prefilled Formalin Vials Market 2018 Outlook, Current and Future Industry Landscape Analysis 2028

The growth of the healthcare industry is expected to play a vital role in shaping the future prospects of the prefilled formalin vials market. Formalin is a derivative of formaldehyde, and prefilled formalin vials are used for tissue fixation. According to a latest research by Future Market Insights (FMI), the global prefilled formalin vials market is projected to account for over US$ 515.8 Mn, in terms of value, by 2028 end. The report on prefilled formalin vials market projects significant growth potential with average compound annual growth rate pegged at 4.1% through 2028.

Prefilled Formalin Vials Market: Overview

According to the new European rules and guidelines, it is essential to protect the environment and the health of the workers who work in an environment where they are directly exposed to aldehydes. Emission of formalin fumes in pathology labs can lead to serious health hazards. The discharge of these fumes can be avoided by using chemical hoods, particularly in operation theatres, where formalin is mostly used. The need to lower the level of formalin emission has surged the demand for prefilled formalin vials, and the growth of the prefilled formalin vials market. In the medical ambulatories including ambulatory surgical centers where small biopsies are performed, the challenges associated with formalin usage are dealt primarily by using prefilled formalin vials or tubes. Direct exposure to formalin increases the risk of developing cancer. Prefilled formalin vials limit the risk of direct exposure to formalin. This factor, in particular, is likely to play an instrumental role in driving the growth of the prefilled formalin vials market.

The prefilled formalin vials can be used for diversified applications in distinct end-use settings such as forensic labs, CROs, emergency medical services, diagnostic laboratories, and veterinary laboratories, among others. Formalin being a cost-effective method of histopathological diagnosis plays a vital role in the healthcare industry, as it cuts down the unnecessary costs associated with the procedural changes related with the usage of new alternative fixatives. In the European Union (EU) in 2017, 971,000 workers were estimated to be exposed to formaldehyde above the background level. Out of these, 175,380 were registered in Italy. Formaldehyde is commonly known to have acute toxicity, resulting in sensory irritation in the eyes and upper respiratory tract. The demand for formalin from veterinary clinics and forensic laboratories has remained stable, but is likely to decline in the near future. This is primarily to due to strict regulations regarding the usage of formalin across the globe.

Prefilled Formalin Vials Market: Segmental Analysis

Prefilled formalin vials are commercially available in different packaging forms in the global prefilled formalin vials market. Of these, 90 – 500 mL prefilled formalin vials are high in demand in the global prefilled formalin vials market, owing to the fact that there is no alternative fixative validated to be served as formalin replacement. Likewise, the 40 – 60 mL prefilled formalin vials segment is also projected to hold significant revenue share as their adoption is increasing in diagnostic and forensic laboratories. Diagnostic laboratories and CROs performing cancer research and diagnostics are the primary consumers of prefilled formalin vials. According to FMI, the contract research organizations segment accounted for over 28.8% revenue share in the global prefilled formalin vials market in 2017.

Formalin is a cost-effective method of histopathology diagnostic in the West and East Asia, owing to which the demand for prefilled formalin vials has increased in the region. Furthermore, the growing incidence of cancer in Asia Pacific due to changing lifestyle of people is likely to boost the growth of the prefilled formalin vials market in the region. Presence of large number of companies with sole focus on providing high-quality prefilled formalin vials and rising disposable income in Japan are factors expected to surge the demand for prefilled formalin vials in the country.

FMI has segmented the global prefilled formalin vials market based on product type and end users. In terms of revenue, the 90 – 500 mL product type segment in the prefilled formalin vials market is expected to hold significant share over the forecast period. In contrary, the <10 mL product type segment in the prefilled formalin vials market is expected to exhibit limited investment opportunities, in terms of revenue, through 2028.

Request Complete TOC Of this Report @ https://www.futuremarketinsights.com/toc/rep-gb-7582

Prefilled Formalin Vials Market: Key Players

The report tracks some of the key companies operating in the prefilled formalin vials market, such as Diapath S.p.A, Histo- Line Laboratories Srl, Cardinal Health, Inc., Leica Microsystems Sales GmbH (Leica Biosystems Nussloch GmbH), Genta Environmental Ltd., Carl Roth GmbH + Co. KG, Magnacol Ltd., Serosep Limited, Ultident Scientific and Solmedia Limited.

Segmentation

The report offers a comprehensive taxonomy of prefilled formalin vials market based on product type, end user and region. The prefilled formalin vials are sold for various types of volume ranges, such as <10 mL, 10 – 20 mL, 20 – 40 mL, 40 – 60 mL, 60 – 90 mL, 90 – 500 mL, and 500 mL – 1 Litre.

These prefilled formalin vials are used by distinct end-use segments in prefilled formalin vials market such as hospitals, clinics, emergency medical services, diagnostic laboratories, academic institutes, forensic laboratories, contract research organizations, veterinary clinics, veterinary laboratories and veterinary hospitals.

The prefilled formalin vials are used for various type of applications, such as cancer diagnostic, forensic research and other types of veterinary diagnostics. The prefilled formalin vials market has been analysed across regions of North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan, Japan and MEA.

Sustained Release Excipients Market 2018 Outlook, Current and Future Industry Landscape Analysis 2026

Future Market Insights offers an exhaustive evaluation of the sustained release excipients landscape in a new research outlook

A recently released global market intelligence outlook on sustained release excipients forecasts the revenue through sustained release excipients to surpass a million dollar value by this year’s end, of which just-under 1/3rd share belongs to North America.

As a growing number of existing international patents are expiring and the prevalence of orthopedic disorders is increasing on the flipside, drug formulations and thereby sustained release excipients are constantly witnessing an impressive manufacturing outlook.

Research identifies the largest revenue shareholding categories in sustained release excipients marketplace on the basis of product type, end user, and route of administration.

  • Polymer is currently the largest product type category worth US$ 300 Mn, whereas gelatin represents the most opportunistic one.
  • While oral route of administration remains highly sought after, injectable is presumed to gradually take over.
  • Biopharmaceutical companies and CMOs pose fierce competition to pharmaceutical companies – the dominant end user of sustained release excipients.

Click here (Preview) for an insightful view of sustained release excipients marketplace.

“The top five players leading the competition in global sustained release excipients landscape account for a collective revenue share of over 50%, whereas a number of relatively small companies represent the rest. A majority of competitors have a limited offering portfolio and significantly depend on product differentiation for an edge in niche treatment areas,” explains a senior research analyst. “Product innovation and market expansion have been the top developmental strategies of companies so far, which are now complemented with strategic partnerships,” the analyst adds further.

Multi-level Partnerships – The Key to Delivering Top Notch Excipient Formulations

FMI underlines the critical role of strategic collaborations – between formulators of sustained release excipients and stakeholders across the value chain – in shaping growth of brands as well as the entire sustained release excipients ecosystem.

While partnerships are expected to prominently focus on spotting the key challenges facing manufacturers, continued education about functionality, variability, and consistency of sustained release excipients is also be an important objective. Drug product manufacturers working in tandem with formulators of sustained release excipients is helping companies deliver best-in-class solutions addressing the most prominent pull factors associated with sustained release excipients.

To best grasp real-time market needs, sustained release excipient formulators are most likely to strengthen interaction with end-use customers. This move offers a dual advantage as a developmental strategy – by helping manufacturers precisely understand and address the challenges facing pharmaceutical markets and stimulating development of new excipient formulations that tap into evolving needs.

A recent deal (2017) involving the combination of The Dow Chemical Company-DuPont-FMC (Health & Nutrition) has been a classic example of collaborative operation, involving channel partners as well as customers.

Request Complete TOC Of this Report @ https://www.futuremarketinsights.com/toc/rep-gb-7580

Growing Impact of Drug Abuse on Public Health

Substance abuse has high impact on the health of individuals and their families. Prolonged drug and alcohol abuse may lead to mental illness and chronic diseases, such as diabetes and heart diseases, cancer, which in turn, can create high economic burden on the society. In order to curb this economic burden caused by drug abuse, governments are focusing on prevention and early intervention strategies are expected to drive demand for drugs of abuse.

For instance, according to the Centers for Disease Control and Prevention (CDC), nearly 10 million individuals aged 55 and above were reported to seek treatment for cancer across the globe. in 2014. Moreover, it is estimated that nearly US$ 600 Bn is spent on addressing the impact caused by substance abuse each year in the U.S.

sustained release excipients market
SegmentationThe report offers a comprehensive taxonomy of sustained release excipients market based on product type, end user, route of administration route, and region. The sustained release excipients are sold for various types of test samples, such as blood, skin, etc. These sustained release excipients are used by pharmaceutical companies, biopharmaceutical companies, neutraceutical companies, and for various type of sustained release excipients, such as food allergies, drug allergies, latex allergies and other types of allergies.

End-use segments in the sustained release excipients market which are a part of this sustained release excipients market report include pharmaceutical companies, biopharmaceutical companies and other end users, such as nutraceutical manufacturers and contract manufacturing organisations. The sustained release excipients market has been analyzed across regions of North America, Latin America, Europe, CIS & Russia, Asia Pacific and MEA.

Cell Line Development Market 2022 Outlook, Current and Future Industry Landscape Analysis 2028

According to International Agency for Research on Cancer, the number of new cancer cases per year is expected to rise to 23.6 million by 2030 globally. In recent times, cell line development and its applications are considered as potential tools in oncology research. Cell lines are projected to be used for development of new treatment pathway for various disease including cancer and neurological diseases.

According to a latest research by Future Market Insights (FMI), the global cell line development market size is anticipated to account for over US$ 7,200 Mn, in terms of value, by 2028 end. The report on cell line development market further projects significant growth potential with CAGR at 7.2% through 2028.

Rapid increase in prevalence of cancer and neurology disorders and lack of efficient treatment solution for these diseases has created the need of more advanced and efficient treatment pathway. Companies and government organizations are investing on research and development activities and are also focusing more on cell line development in search of new cellular pathway to develop novel drugs. The increased spending on biosimilar R&D from exiting biopharmaceutical companies would provide boost to cell line development market.

In recent time the contract research organizations are focusing on cell line development and cell line research activities. According to National Institutes of Health (NIH) the estimated total federal spending on all type of stem cell line research for 2017 is US$ 1.58 Bn. In developing countries like India, government is supporting cell line development through national funding agencies like Department of Biotechnology (DBT), Indian Council of Medical Research (ICMR), and Department of Science and Technology (DST).

Regenerative medicines are the next generation treatment solution and Cell Line Development or Cell Culture is a vital part for regenerative medicine. Increasing demand of regenerative medicines in cancer treatment would positively impacting the growth of Cell Line Development market over the forecast period.

The biopharmaceutical companies operating in development of novel drug line are expected to hold promising revenue opportunity in cell line development market.

Request Complete TOC Of this Report @ https://www.futuremarketinsights.com/toc/rep-gb-7566

Sales Analysis of Cell line Development from 2013 to 2021 Vs Market Outlook for 2022 to 2028

The market value for cell line development holds nearly 11.7% of the overall US$ 37.3 Mn drug discovery market in 2021.

Compared to the existing mammalian expression systems, the human cell lines possess the ability to produce proteins analogous to naturally synthesized proteins in the human body. This property is advantageous for the advancement in protein therapeutics, and acts as a heavy driver towards the growth of the biopharmaceutical industry. The growth of these industries pulls up the demand of cell line development market. The advantage of using human cell lines for protein production is factored in through the prospects of the resultant recombinant protein to bear post-translational modifications which are consistent with the endogenous human proteins.

Increasing burden of disease had propelled the development of new treatment pathways for diseases such as cancer and neurological disorders. The applications of hybridoma cell lines and recombinant cell lines in the development of therapeutic proteins has led to the growth in demand of cell line development market. The human cell lines, specifically the stem cell lines hold a potential stance for the treatment of various degenerative diseases, and hence paves way to novel drug therapy in regenerative medicine.

Moreover, the increasing development and production of biosimilars, owing to the patent expiry of branded therapeutics has positively impacted the growth of the cell line development market. The global scale development of bio therapeutics with cell line development has further fostered the development of a number of protein based therapeutics, assisting the growth of high-expression cell lines. These factors promote the expansion of the cell line development market on a global scale.

The global cell line development market expanded at 6.1% CAGR over the past 8 years from 2013 to 2021. The market is expected to expand at a considerable growth rate over the next six years (2022-2028) at a CAGR of close to 7.5%

cell line development market

Future Market Insights (FMI) has segmented the cell line development market based on product type, cell line source type, end user, type of cell line and region.

Product type segment in cell line development market is segmented into media and reagents, equipment and accessories. Reagents and Media are required from incubation to preservation of cell lines. These products are expensive and have repetitive use in cell culture or bio-production. Reagent and media segment in cell line development market is expected witness noteworthy growth in terms of revenue owing to rapid increase in demand in cell culture and cell based assays.

Cell line development market by cell line source is categorized into mammalian cells and non-mammalian cells. Mammalian cell line development is anticipate to witness significant growth in overall cell line development market. This growth of mammalian cells segment in cell line development market is driven by increased production of biologics drugs which require mammalian cells. Increasing antibody production is the major driving factor behind the growth of mammalian cell lines segment in cell line development market.

Mammalian cell lines are used to create therapeutic proteins through genetic building and antibodies through viral infection. For example, Gaucher’s disease, which is a genetic disorder characterized by lack of β-glucocerebrosidase enzyme and can be treated by Cerezyme which is a recombinant enzyme produces in mammalian cell lines. Mammalian cell lines are also useful in production of antibodies and other therapeutic agents such as specific binding proteins that can neutralize disease causing agents in the body. For example Under cell line type segment in cell line development market, recombinant cell line development are the most demanding type of cell line due to large application in biologics production, protein interaction, gene activation, toxicity testing and drug screening.

Growing application recombinant cell line development in drug toxicity testing is expected to boost the growth of overall cell line development during the forecast period

North America and Europe cell line development market will dominate in owing to increasing government funding in cell line development research and rising spending on biosimilar developments. Asia Pacific cell line development market is expected to grow at a high growth rate due to increased number of research organization engaged in novel biologics and biosimilar fastest revenue growth in overall cell line development market.

The Asia Pacific region in Cell line development market is anticipate to witness increasing demand of biopharmaceuticals and regenerative medicines are expected to boost the growth of the cell line development market.

FMI’s report tracks some of the key companies operating in the cell line development market, such as Selexis SA, GE Healthcare, Corning Incorporated, Thermo Fischer Scientific, Inc., American Type Culture Collection (ATCC), Lonza (Sartorius Stedim Biotech S.A.), Danaher Corporation, Merck KGaA, WuXi Biologics.

Key Market Segments Covered in Cell line development Market Research

By Product Type:

  • Reagent and Media
  • Equipment
  • Accessories and consumables

By Source Type:

  • Mammalian cell line
  • Non-mammalian cell line

By End User:

  • Biopharmaceutical Companies
  • Contract Research Organizations
  • Academics and Research Institutes
  • Biotechnology Companies

By Cell Lines:

  • Recombinant cell lines
  • Hybridomas
  • Continuous cell lines
  • Primary cell lines

By Region:

  • North America
  • Latin America
  • Europe
  • CIS & Russia
  • Japan
  • APEJ
  • MEA

Transportation Composites Market Exhibits a Stunning Growth Potentials

Transportation composites’ compatibility with the broader objectives of the automotive industry, notably sustainability and weight reduction, will drive sustained adoption, according to a new report by Future Market Insights (FMI).

The report offers a 10-year outlook on the transportation composites market, offering analysis across key segments in 20+ countries.

According to the study, consistent innovation and research into technologies that help meet legislated emission targets are becoming the elixir for manufacturers of transportation composites. Moreover, as customers are become more environmentally conscious, reuse and recycling is gaining traction – a development that augurs well for transportation composite manufacturers.

In a bid to fulfil emissions targets and improve the sustainability of future automobiles, mass reduction of automobiles (lightweighting) is increasingly emerging as major challenge for automotive manufacturers.

Lightweight vehicles help achieve improved fuel efficiency as well as offer better braking, acceleration, and handling.

As these trends propelling the current surge will sustain, transportation composite manufacturers are focusing on distinctive capabilities and continue to explore opportunities to better serve customers and make material progress.

To remain ‘ahead’ of your competitors, request for @

https://www.futuremarketinsights.com/reports/sample/rep-gb-12337

Transportation Composites Market Size Study

  • Demand for lightweight components to drive market growth
  • Glass fiber transportation composites remain preferable owing to their superior properties such as high strength and durability
  • Thermosetting composites stay in-demand through 2030, given their umpteen strength that makes them ideal for high-temperature conditions
  • Market players continue to reap substantial gains from Asia Pacific (APAC) over the following decade

“Over 100 models in automotive industry currently leverage carbon fiber reinforced plastic (CRFP) for OEM components. The OEMs are banking on transportation composites to curb vehicle emissions, decrease vehicle weight, and thus, enhance fuel efficacy,” says analyst at FMI.

COVID-19 Impact on Transportation Composites Market

The transportation composites market is heavily dependent on the automotive production and sales across the world. Sudden shutdowns of manufacturing units in China and its ripple effect, resulting in large-scale havoc among global automotive manufacturers, have been felt subsequently in the US, Europe, South America, and India. Moreover, majority of prominent global automakers import 30-60% of their components from China such as sub-assemblies, and modules.

As several automotive OEMs and distributors have offshored their production activities to low-cost regions, they are currently scrambling to set up shorter or localized regional supply chains.

Moving ahead, nationwide lockdowns in worst-affected countries have impacted the transportation composites market at multiple fronts including, financially drained SMEs, disturbed supply chains, and dampened sales in Q1 of 2020. Moreover, the effects have spilled over into Q2, with incomplete order deliveries due to ongoing production downturns.

Contact Sales for Further Assistance in Purchasing this Report@

https://www.futuremarketinsights.com/checkout/12337

Transportation Composites Market – Competitive Intelligence

The global transportation composites market is moderately fragmented, with presence of leading players exhibiting expertise in advanced manufacturing techniques. In a bid to sustain their revenue pool in the global marketplace over long run, market players are focusing on conspicuous investments in innovation and diversification.

  • Toray Industries develops carbon fiber transportation composites derived from polyacrylonitrile (PAN). These composites, in various forms, are used in automotive and several other use cases
  • Solvay S.A. produces an entire range of thermoplastic transportation composites – Evolite™ – for demanding applications. These products contain polyphthalamide (PPA) and polyphenylene sulfide (PPS)

Want To Know More About Transportation Composites Market?

A new market research report published by Future Market Insights (FMI) on the global transportation composites market report offers comprehensive insights into the market demand trends and analysis of opportunities over the forecast period, 2020-2030. The report examines the transportation composites market through five different segments – material type, resin, application, vehicle type, and region. The transportation composites market report also provides extensive assessment of pricing by different key market dynamics, life cycle analysis, and technologies that are being deployed in the manufacturing of transportation composites and product adoption across several end-use industries.

About Chemicals & Materials division of FMI

The Chemicals & Materials division at FMI offers distinct and pin-point analysis about the chemicals & materials industry. Coverage of the chemicals and materials  market extends from commodity, bulk, specialty and petrochemicals to advanced materials, composites, and nanotechnology. The team also puts special emphasis on ‘green alternatives’, recycling and renewable technology developments, and supply-demand trade assessment. Our research studies are widely referred by chemical manufacturers, research institutions, channel partners, and government bodies for developing – ‘The Way Forward’.